ask="9.11"
ask_size="1100"
average_daily_volume="243974"
bid="7.50"
bid_size="1000"
book_value="3.42"
change="-0.04"
change_from_200_day_moving_average="-0.25"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-4.70"
change_From_52_week_low="2.21"
change_in_percent="-0.51%"
close="7.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.07"
ebitda="-1.40M"
eps_estimate_current_year="-2.94"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-2.63"
ex_dividend_date="N/A"
float_shares="4868000"
high="7.88"
high_52_weeks="12.50"
last_trade_date="2/28/2017"
last_trade_price="7.80"
last_trade_size="1803"
last_trade_time="4:00pm"
low="7.61"
low_52_weeks="5.59"
market_capitalization="94.87M"
moving_average_200_day="8.05"
moving_average_50_day="7.61"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.80"
open="7.88"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.10%"
percent_change_from_50_day_moving_average="+2.46%"
percent_change_from_52_week_high="-37.60%"
percent_change_from_52_week_low="+39.53%"
previous_close="7.84"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.29"
price_per_sales="1.39"
revenue="68.73M"
shares_outstanding="12163000"
short_ratio="3.68"
stock_exchange="NCM"
symbol="REPH"
volume="37325"
weeks_range_52="5.59 - 12.50"
